Numerous Side Events At WIPO General Assembly This Week 22/09/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment A number of side events have been scheduled during the annual General Assemblies of the World Intellectual Property Organization this week. The range of events are organised by WIPO as well as governmental and non-governmental organisations working in areas such as public health, finance, copyright, geographical indications and innovation.
Is The Development Dimension Of WIPO Incompatible With Its Role Of IP Protection? 18/09/2014 by Catherine Saez, Intellectual Property Watch 4 Comments The World Intellectual Property Organization is a successful United Nations agency if success is measured by its generated income and the number of international registrations of intellectual property titles. However, in its role as a norm-setting United Nations agency, the organisation has been struggling for the past year as member countries have quite a different view on its core objectives.
Top Officials Proposed For WIPO; Tied To Director’s Term 17/09/2014 by William New, Intellectual Property Watch 2 Comments After months of consideration and an application process that attracted 360 applicants, the World Intellectual Property Organization secretariat has made public its proposed names for the top posts at the UN agency for the next six years. Only four out of eight names are newcomers, and all will be tied to the term of service […]
For Experts, Questions Still Abound On IP And Standard-Setting 16/09/2014 by Magda Voltolini for Intellectual Property Watch Leave a Comment BRUSSELS – Intellectual property experts at the annual conference of the European Policy for Intellectual Property Association (EPIP) discussed a range of topics including IP rights and standard-setting. The conclusion? Many questions remain unanswered.
Experts Look At The Meaning Of Myriad Case, One Year Later 16/09/2014 by Brittany Ngo for Intellectual Property Watch Leave a Comment IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later – what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?
Guest Post: Nine Mandatory Licences Allow Greater Access To Medicines In Ecuador 12/09/2014 by Intellectual Property Watch, Intellectual Property Watch 1 Comment What is a mandatory licence? Mandatory licenses are a legal remedy within the intellectual property flexibilities provided by the World Trade Organization allowing a government to grant permission to third parties to produce a patented product or use a patented process without the consent of the patentee, in order to address a priority status for the country.
Old (former IPR-Thieving) Napster v New (IPR-Thieving) Napster.fm? 11/09/2014 by William New, Intellectual Property Watch 2 Comments The World Intellectual Property Organization this week released the decision in an internet domain name dispute in which the current incarnation of the once-wildly successful Napster music-sharing website successfully forced a website called napster.fm to shut down over intellectual property rights violations. Is Napster still cool?
India’s IP Policy On Stage As Modi Heads To US 05/09/2014 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment Will India’s new government bring in radical changes in the country’s intellectual property rights regime? That question has generated enormous buzz but no definitive answer ever since the Bharatiya Janata Party (BJP) swept to power with a decisive mandate in May this year. [Update: the Indian government has announced that it has begun a process for a comprehensive IPR policy over the next six months, including a government think tank. See report here. The government website is here.]
Industry Applauds Marti Nomination As US IP Enforcement Coordinator 01/09/2014 by Intellectual Property Watch Leave a Comment The US IP industry is applauding the nomination of trademark attorney Daniel Marti to be the next US Intellectual Property Enforcement Coordinator.
Biosimilar Medicines Need Strong Regulation, IP Crucial For Innovation, Pharma Says 29/08/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment Biosimilar medicines might prove to be a new reservoir for innovation for the pharmaceutical industry. However, the complexity of their manufacture needs a stringent regulatory framework, according to the industry.